Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysisParambir S. Dulai, Rohit Loomba|Hepatology|2017Cited by 1.9k
Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severityRobert H. Mills, David J. Gonzalez, Parambir S. Dulai et al.|Nature Microbiology|2022Cited by 385
Obefazimod in patients with moderate-to-severely active ulcerative colitis: efficacy and safety analysis from the 96-week open-label maintenance phase 2b studySéverine Vermeire, Bruce E. Sands, Josianne Nitcheu et al.|Journal of Crohn s and Colitis|2025Cited by 10
Comment on “Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis”Richárd Kellermayer, Harland S. Winter, Peter Lewindon et al.|Therapeutic Advances in Gastroenterology|2025Cited by 2
130 Efficacy and Safety of Obefazimod in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Two, Phase 3, Randomised, Double-Blind, Placebo-Controlled, 8-Week Induction Trials (ABTECT-1 and 2)Bruce E. Sands, Séverine Vermeire, Silvio Danese et al.|The American Journal of Gastroenterology|2025Cited by 1